Youbin Cui

964 total citations
38 papers, 562 citations indexed

About

Youbin Cui is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Youbin Cui has authored 38 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Youbin Cui's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Myasthenia Gravis and Thymoma (5 papers). Youbin Cui is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (5 papers) and Myasthenia Gravis and Thymoma (5 papers). Youbin Cui collaborates with scholars based in China, Finland and Japan. Youbin Cui's co-authors include Hongfei Cai, Zheng Ma, Tianyu Lu, Rui Wang, Yan Zhang, Yanzhong Xin, Liang Chang, Shuai Bian, Yan Song and Wanguo Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Nanoscale.

In The Last Decade

Youbin Cui

38 papers receiving 554 citations

Peers

Youbin Cui

SURGE

PRM

ONCOL

Wei‐Xia Peng Japan

Marco Pezzullo Italy

Sergiu Paşca Romania

Chih‐Kung Lin Taiwan

Hongli Song China

Zhen Xu China

Kenneth B. Fallon United States

Stephen P. Maloney United States

Xiaomeng Yi China

Wei‐Xia Peng Japan

Youbin Cui

236 ×0.9

106 ×0.6

91 ×0.9

SURGE

99 ×1.1

PRM

128 ×1.5

ONCOL

Citations per year, relative to Youbin Cui Youbin Cui (= 1×) peers Wei‐Xia Peng

Countries citing papers authored by Youbin Cui

Since Specialization

Citations

This map shows the geographic impact of Youbin Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youbin Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youbin Cui more than expected).

Fields of papers citing papers by Youbin Cui

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youbin Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youbin Cui. The network helps show where Youbin Cui may publish in the future.

Co-authorship network of co-authors of Youbin Cui

This figure shows the co-authorship network connecting the top 25 collaborators of Youbin Cui. A scholar is included among the top collaborators of Youbin Cui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youbin Cui. Youbin Cui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yonghui, Chang Liu, Xiaodong Ma, et al.. (2024). Encapsulated mitochondria to reprogram the metabolism of M2-type macrophages for anti-tumor therapy. Nanoscale. 16(45). 20925–20939. 3 indexed citations

Li, Congcong, et al.. (2024). Analysis of the influencing factors in the long-term survival of esophageal cancer. Frontiers in Oncology. 13. 1274014–1274014. 5 indexed citations

Li, Congcong, Hongfei Cai, Fanyu Meng, et al.. (2023). Case report: Lung transplantation for treatment of paraquat intoxication: timing of transplantation. Frontiers in Pharmacology. 14. 1205689–1205689. 5 indexed citations

Wang, Rui, et al.. (2023). A new method for evaluating lung volume: AI-3D reconstruction. Frontiers in Physiology. 14. 1217411–1217411. 2 indexed citations

Wang, Rui, et al.. (2023). Analysis of drug resistance in pulmonary tuberculosis patients with positive sputum tuberculosis culture in Northeast China. Frontiers in Pharmacology. 14. 1263726–1263726. 1 indexed citations

Qin, Da, Hongfei Cai, Qing Liu, et al.. (2023). Nomogram model combined thrombelastography for venous thromboembolism risk in patients undergoing lung cancer surgery. Frontiers in Physiology. 14. 1242132–1242132. 3 indexed citations

Yang, Yue, et al.. (2023). Clinical application of liquid biopsy based on circulating tumor DNA in non-small cell lung cancer. Frontiers in Physiology. 14. 1200124–1200124. 6 indexed citations

Cui, Yu, et al.. (2023). The relationship between autophagy and PD-L1 and their role in antitumor therapy. Frontiers in Immunology. 14. 1093558–1093558. 12 indexed citations

Cai, Hongfei, et al.. (2022). FSCN1 Promotes Esophageal Carcinoma Progression Through Downregulating PTK6 via its RNA-Binding Protein Effect. Frontiers in Pharmacology. 13. 868296–868296. 2 indexed citations

10.

Guo, Wei, Guang Chen, Wencan Li, et al.. (2020). Lnc-MCEI mediated the chemosensitivity of esophageal squamous cell carcinoma via miR-6759-5p to competitively regulate IGF2. International Journal of Biological Sciences. 16(15). 2938–2950. 14 indexed citations

11.

Tang, Ze, Hongfei Cai, Rui Wang, & Youbin Cui. (2018). Overexpression of CD300A inhibits progression of NSCLC through downregulating Wnt/β-catenin pathway. OncoTargets and Therapy. Volume 11. 8875–8883. 8 indexed citations

12.

Cai, Hongfei, Rui Wang, Yang Li, Xiaodong Yang, & Youbin Cui. (2018). Role of 3D reconstruction in the evaluation of patients with lower segment oesophageal cancer. Journal of Thoracic Disease. 10(7). 3940–3947. 6 indexed citations

13.

Ma, Zheng, Hongfei Cai, Yan Zhang, Liang Chang, & Youbin Cui. (2017). MiR-129-5p inhibits non-small cell lung cancer cell stemness and chemoresistance through targeting DLK1. Biochemical and Biophysical Research Communications. 490(2). 309–316. 57 indexed citations

14.

Xin, Yanzhong, Hongfei Cai, Yang Li, & Youbin Cui. (2017). Thymic hyperplasia associated with primary Sjogren’s syndrome cured by thymectomy. Journal of Thoracic Disease. 9(2). E130–E132. 8 indexed citations

15.

Cui, Youbin, et al.. (2016). Myasthenia gravis in patients with thymoma affects survival rate following extended thymectomy. Oncology Letters. 11(6). 4177–4182. 29 indexed citations

16.

Liu, Xiyu, Yan Song, Guifeng Liu, et al.. (2015). NADPH oxidase 1-dependent ROS is crucial for TLR4 signaling to promote tumor metastasis of non-small cell lung cancer. Tumor Biology. 36(3). 1493–1502. 58 indexed citations

17.

Zhang, Zhefeng, et al.. (2014). Screening and selection of peptides specific for esophageal cancer cells from a phage display peptide library. Journal of Cardiothoracic Surgery. 9(1). 76–76. 13 indexed citations

18.

Zhang, Zhefeng, Feng Jin, Liguang Sun, et al.. (2014). Inflammatory pseudotumor of the thymus: A case report and review of the literature. Oncology Letters. 7(5). 1414–1418. 1 indexed citations

19.

Wang, Keren, et al.. (2010). Interaction between BRCA1/BRCA2 and ATM/ATR associate with breast cancer susceptibility in a Chinese Han population. Cancer Genetics and Cytogenetics. 200(1). 40–46. 12 indexed citations

20.

Cui, Youbin. (2007). NUSS procedure for the correction of pectus excavatum. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact